Sulpiride augmentation of olanzapine in the management of treatment-resistant chronic schizophrenia: Evidence for improvement of mood symptomatology

International Clinical Psychopharmacology

Volumn 19, Issue 1, 2004, Pages 23-26

  Kotler, Moshe ^a,b   Strous, Rael D ^a,b   Reznik, Ilya ^a,b   Shwartz, Sima ^a,b   Weizman, Abraham ^b,c   Spivak, Baruch ^a,b  

^a NESS ZIONA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

Depression; Extrapyramidal symptoms; Olanzapine; Schizophrenia; Sulpiride

Indexed keywords

OLANZAPINE; SULPIRIDE;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG SAFETY; EVALUATION; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GENERAL CONDITION IMPROVEMENT; HAMILTON SCALE; HUMAN; MALE; MENTAL PATIENT; MONOTHERAPY; MOOD DISORDER; NEGATIVE SYNDROME; POSITIVE SYNDROME; PRIORITY JOURNAL; RANDOMIZATION; SCHIZOPHRENIA; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AFFECT; ANTIPSYCHOTIC AGENTS; ANXIETY; BASAL GANGLIA DISEASES; BENZODIAZEPINES; CHRONIC DISEASE; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SULPIRIDE;

EID: 1642534546     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200401000-00004     Document Type: Article

References (20)

1. Barnes TRE (1989). A rating scale for drug-induced akathisia. Br J Psychiatry 154:672-676.
2. Braftos O, Haug JO (1979). Comparison of sulpiride and chlorpromazine in psychoses. A double blind multicenter study. Acta Psychiatr Scand 60:1-9.
3. Cassano O, Castrogiovanni P, Conti L (1975). Sulpiride versus haloperidol in schizophrenia: a double blind comparative trial. Curr Therap Res 17: 189-201.
4. Drago F, Arezzi A, Virzi A (2000). Effects of acute or chronic administration of substituted benzamides in experimental models of depression in rats. Eur Neuropsychopharmacol 10:437-442.
5. Elizur A, Davidson S (1975). The evaluation of the anti-autistic activity of sulpiride. Curr Ther Res Clin Exp 18:578-584.
6. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Version (SCID-P), version 2. New York: New York State Psychiatric Institute, Biometrics Research; 1994.
7. Hamilton M (1959). The assessment of anxiety scales by rating. Br J Med Psychol 32:50-55.
8. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
9. Jenner P, Marsden CD (1981). Substituted benzamide drugs as selective neuroleptic agents. Neuropharmacology 20:1285-1293.
10. Kane J, Honigfeld G, Singer J, Meltzer H (1988). Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789-796.
11. Kane JM (1999). Pharmacologic treatment of schizophrenia. Biol Psychiatry 46:1396-1408.
12. Kapur S, Remington G (1996). Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153:466-476.
13. Kay S, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale for schizophrenia. Schizophr Bull 13:261-276.
14. Leopola U, Koskinen T, Rimon R (1989). Sulpiride and perphehazine in schizophrenia. A double blind clinical trial. Acta Psychiatr Scand 80:92-96.
15. Meltzer HY (1992). The importance of serotonin-dopamine interactions in the action of clozapine. Br J Psychiatry 17 (suppl):22-29.
16. Pani L, Gessa GL (2002). The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia. Mol Psychiatry 7:247-253.
17. Raskin S, Durst R, Katz G, Zislin J (2000). Olanzapine and sulpiride a preliminary study of combination/augmentation in patients with treatment-resistant schizophrenia. J Clin Psychopharmacol 20:500-503.
18. Shiloh R, Zemishlany Z, Aizenberg D, Radwan M, Schwartz B, Dorfman-Etrog P, Modai I, Khaikin M, Weizman A (1997). Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind placebo controlled study. Br J Psychiatry 171:569-573.
19. Simpson G, Angus JWS (1970). A rating scale for extrapyramid side effects. Acta Psychiatr Scand 45 (suppl 212):11-19.
20. Tagliamonte A, DeMontis G, Olianas M, Vargiu L, Corsini GU, Gessa GL (1975). Selective increase of brain dopamine synthesis by sulpiride. J Neurochem 24:707-710.